Tessa Goetghebuer1, Kinga K Smolen2, Catherine Adler1, Jishnu Das3,4, Trevor McBride5, Gaby Smits6, Sandra Lecomte2, Edwige Haelterman1, Patricia Barlow7, Pedro A Piedra5,8, Fiona van der Klis6, Tobias R Kollmann9, Douglas A Lauffenburger4, Galit Alter3, Jack Levy1, Arnaud Marchant2. 1. Department of Pediatrics, Hôpital Saint-Pierre, Brussels. 2. Institute for Medical Immunology, Université libre de Bruxelles, Charleroi, Belgium. 3. Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts. 4. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts. 5. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas. 6. National Institute of Health and the Environment, Bilthoven, The Netherlands. 7. Department of Obstetrics and Gynecology, Hôpital Saint-Pierre, Brussels, Belgium. 8. Department of Pediatrics, Baylor College of Medicine, Houston, Texas. 9. Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, Canada.
Abstract
BACKGROUND: Epidemiological studies conducted in low- and high-income countries showed that infants exposed to maternal human immunodeficiency virus (HIV) have a high risk of severe infections. Immune alterations during fetal life have been proposed as a possible mechanism. METHODS: This prospective study assessed the relative risk of hospitalization for infection in HIV-exposed uninfected (HEU) infants as compared to HIV-unexposed (HU) infants born in a high-income country (HIC). Markers of monocyte activation and levels of pathogen-specific antibodies were measured at birth to identify correlates of infant susceptibility. RESULTS: There were 27 of 132 HEU infants and 14 of 123 HU infants hospitalized for infection during the first year of life (adjusted hazard ratio [aHR] 2.33, 95% confidence interval [CI] 1.10-4.97). Most of this increased risk was associated with the time of initiation of maternal antiretroviral therapy (ART). As compared to HU infants, the risk of hospitalization for infection of HEU infants was 4-fold higher when mothers initiated ART during pregnancy (aHR 3.84, 95% CI 1.69-8.71) and was not significantly increased when ART was initiated before pregnancy (aHR 1.42, 95% CI 0.58-3.48). The activation of newborn monocytes and the reduced transfer of maternal antibodies were most intense following ART initiation during pregnancy, and predicted the risk of infant hospitalization. CONCLUSIONS: These observations indicate that initiation of maternal ART before pregnancy reduces the susceptibility of HEU infants born in a HIC to severe infections, and that this effect could be related to the prevention of immune alterations during fetal life.
BACKGROUND: Epidemiological studies conducted in low- and high-income countries showed that infants exposed to maternal human immunodeficiency virus (HIV) have a high risk of severe infections. Immune alterations during fetal life have been proposed as a possible mechanism. METHODS: This prospective study assessed the relative risk of hospitalization for infection in HIV-exposed uninfected (HEU) infants as compared to HIV-unexposed (HU) infants born in a high-income country (HIC). Markers of monocyte activation and levels of pathogen-specific antibodies were measured at birth to identify correlates of infant susceptibility. RESULTS: There were 27 of 132 HEU infants and 14 of 123 HU infants hospitalized for infection during the first year of life (adjusted hazard ratio [aHR] 2.33, 95% confidence interval [CI] 1.10-4.97). Most of this increased risk was associated with the time of initiation of maternal antiretroviral therapy (ART). As compared to HU infants, the risk of hospitalization for infection of HEU infants was 4-fold higher when mothers initiated ART during pregnancy (aHR 3.84, 95% CI 1.69-8.71) and was not significantly increased when ART was initiated before pregnancy (aHR 1.42, 95% CI 0.58-3.48). The activation of newborn monocytes and the reduced transfer of maternal antibodies were most intense following ART initiation during pregnancy, and predicted the risk of infant hospitalization. CONCLUSIONS: These observations indicate that initiation of maternal ART before pregnancy reduces the susceptibility of HEU infants born in a HIC to severe infections, and that this effect could be related to the prevention of immune alterations during fetal life.
Authors: Nelly Amenyogbe; Pedro Dimitriu; Patricia Cho; Candice Ruck; Edgardo S Fortuno; Bing Cai; Ariane Alimenti; Hélène C F Côté; Evelyn J Maan; Amy L Slogrove; Monika Esser; Arnaud Marchant; Tessa Goetghebuer; Casey P Shannon; Scott J Tebbutt; Tobias R Kollmann; William W Mohn; Kinga K Smolen Journal: J Immunol Date: 2020-10-16 Impact factor: 5.422
Authors: Chaya D Patel; Iara M Backes; Sean A Taylor; Yike Jiang; Arnaud Marchant; Jean M Pesola; Donald M Coen; David M Knipe; Margaret E Ackerman; David A Leib Journal: Sci Transl Med Date: 2019-04-10 Impact factor: 17.956
Authors: Madeleine F Jennewein; Ilona Goldfarb; Sepideh Dolatshahi; Cormac Cosgrove; Francesca J Noelette; Marina Krykbaeva; Jishnu Das; Aniruddh Sarkar; Matthew J Gorman; Stephanie Fischinger; Carolyn M Boudreau; Joelle Brown; Jennifer H Cooperrider; Jasneet Aneja; Todd J Suscovich; Barney S Graham; Georg M Lauer; Tessa Goetghebuer; Arnaud Marchant; Douglas Lauffenburger; Arthur Y Kim; Laura E Riley; Galit Alter Journal: Cell Date: 2019-06-13 Impact factor: 41.582
Authors: Stanzi M le Roux; Elaine J Abrams; Kirsten A Donald; Kirsty Brittain; Tamsin K Phillips; Allison Zerbe; David M le Roux; Max Kroon; Landon Myer Journal: Lancet Child Adolesc Health Date: 2020-01-10